List of Tables
Table 1. Global Furosemide Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Furosemide Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Furosemide Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Furosemide Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Furosemide Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Furosemide Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Furosemide Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Furosemide Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Furosemide Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Furosemide Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Furosemide Injection, Product Type & Application
Table 12. Global Key Manufacturers of Furosemide Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Furosemide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Furosemide Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Furosemide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Furosemide Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Furosemide Injection Sales Market Share by Region (2020-2025)
Table 19. Global Furosemide Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Furosemide Injection Sales Market Share by Region (2026-2031)
Table 21. Global Furosemide Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Furosemide Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Furosemide Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Furosemide Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Furosemide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Furosemide Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Furosemide Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Furosemide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Furosemide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Furosemide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Furosemide Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Furosemide Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Furosemide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Furosemide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Furosemide Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Furosemide Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Furosemide Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Furosemide Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Furosemide Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Furosemide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Furosemide Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Furosemide Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Furosemide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Furosemide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Furosemide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Furosemide Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Furosemide Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Furosemide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Furosemide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Furosemide Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Furosemide Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Furosemide Injection Sales Market Share by Type (2020-2025)
Table 53. Global Furosemide Injection Sales Market Share by Type (2026-2031)
Table 54. Global Furosemide Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Furosemide Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Furosemide Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Furosemide Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Furosemide Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Furosemide Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Furosemide Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Furosemide Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Furosemide Injection Sales Market Share by Application (2020-2025)
Table 63. Global Furosemide Injection Sales Market Share by Application (2026-2031)
Table 64. Global Furosemide Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Furosemide Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Furosemide Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Furosemide Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Furosemide Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Furosemide Injection Price (US$/Unit) by Application (2026-2031)
Table 70. AuroMedics Company Information
Table 71. AuroMedics Description and Business Overview
Table 72. AuroMedics Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. AuroMedics Furosemide Injection Product
Table 74. AuroMedics Recent Developments/Updates
Table 75. Baxter Company Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Baxter Furosemide Injection Product
Table 79. Baxter Recent Developments/Updates
Table 80. Fresenius Kabi Company Information
Table 81. Fresenius Kabi Description and Business Overview
Table 82. Fresenius Kabi Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Fresenius Kabi Furosemide Injection Product
Table 84. Fresenius Kabi Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Furosemide Injection Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Avet Pharmaceuticals Company Information
Table 91. Avet Pharmaceuticals Description and Business Overview
Table 92. Avet Pharmaceuticals Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Avet Pharmaceuticals Furosemide Injection Product
Table 94. Avet Pharmaceuticals Recent Developments/Updates
Table 95. SteriMax Company Information
Table 96. SteriMax Description and Business Overview
Table 97. SteriMax Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. SteriMax Furosemide Injection Product
Table 99. SteriMax Recent Developments/Updates
Table 100. Hunan Kelun Pharmaceutical Company Information
Table 101. Hunan Kelun Pharmaceutical Description and Business Overview
Table 102. Hunan Kelun Pharmaceutical Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Hunan Kelun Pharmaceutical Furosemide Injection Product
Table 104. Hunan Kelun Pharmaceutical Recent Developments/Updates
Table 105. Hainan Huanglong Pharm Company Information
Table 106. Hainan Huanglong Pharm Description and Business Overview
Table 107. Hainan Huanglong Pharm Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Hainan Huanglong Pharm Furosemide Injection Product
Table 109. Hainan Huanglong Pharm Recent Developments/Updates
Table 110. Shenyang Guagnda Pharm Company Information
Table 111. Shenyang Guagnda Pharm Description and Business Overview
Table 112. Shenyang Guagnda Pharm Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Shenyang Guagnda Pharm Furosemide Injection Product
Table 114. Shenyang Guagnda Pharm Recent Developments/Updates
Table 115. Shagnhai Harvest Pharamceutical Company Information
Table 116. Shagnhai Harvest Pharamceutical Description and Business Overview
Table 117. Shagnhai Harvest Pharamceutical Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shagnhai Harvest Pharamceutical Furosemide Injection Product
Table 119. Shagnhai Harvest Pharamceutical Recent Developments/Updates
Table 120. Chengdu Brilliant Pharmaceutical Company Information
Table 121. Chengdu Brilliant Pharmaceutical Description and Business Overview
Table 122. Chengdu Brilliant Pharmaceutical Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Chengdu Brilliant Pharmaceutical Furosemide Injection Product
Table 124. Chengdu Brilliant Pharmaceutical Recent Developments/Updates
Table 125. Changbaishan Pharmaceutical Company Information
Table 126. Changbaishan Pharmaceutical Description and Business Overview
Table 127. Changbaishan Pharmaceutical Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Changbaishan Pharmaceutical Furosemide Injection Product
Table 129. Changbaishan Pharmaceutical Recent Developments/Updates
Table 130. CSPC Ouyi Pharm Company Information
Table 131. CSPC Ouyi Pharm Description and Business Overview
Table 132. CSPC Ouyi Pharm Furosemide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. CSPC Ouyi Pharm Furosemide Injection Product
Table 134. CSPC Ouyi Pharm Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Furosemide Injection Distributors List
Table 138. Furosemide Injection Customers List
Table 139. Furosemide Injection Market Trends
Table 140. Furosemide Injection Market Drivers
Table 141. Furosemide Injection Market Challenges
Table 142. Furosemide Injection Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Furosemide Injection
Figure 2. Global Furosemide Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Furosemide Injection Market Share by Type: 2024 & 2031
Figure 4. 20mg/2ml Product Picture
Figure 5. 40mg/40ml Product Picture
Figure 6. 100mg/10ml Product Picture
Figure 7. Global Furosemide Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Furosemide Injection Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Clinics
Figure 11. Recovery Center
Figure 12. Global Furosemide Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Furosemide Injection Market Size (2020-2031) & (US$ Million)
Figure 14. Global Furosemide Injection Sales (2020-2031) & (K Units)
Figure 15. Global Furosemide Injection Average Price (US$/Unit) & (2020-2031)
Figure 16. Furosemide Injection Report Years Considered
Figure 17. Furosemide Injection Sales Share by Manufacturers in 2024
Figure 18. Global Furosemide Injection Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Furosemide Injection Players: Market Share by Revenue in Furosemide Injection in 2024
Figure 20. Furosemide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Furosemide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Furosemide Injection Sales Market Share by Country (2020-2031)
Figure 23. North America Furosemide Injection Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Furosemide Injection Sales Market Share by Country (2020-2031)
Figure 27. Europe Furosemide Injection Revenue Market Share by Country (2020-2031)
Figure 28. Germany Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Furosemide Injection Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Furosemide Injection Revenue Market Share by Region (2020-2031)
Figure 35. China Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Furosemide Injection Sales Market Share by Country (2020-2031)
Figure 46. Latin America Furosemide Injection Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Furosemide Injection Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Furosemide Injection Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Furosemide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Furosemide Injection by Type (2020-2031)
Figure 56. Global Revenue Market Share of Furosemide Injection by Type (2020-2031)
Figure 57. Global Furosemide Injection Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Furosemide Injection by Application (2020-2031)
Figure 59. Global Revenue Market Share of Furosemide Injection by Application (2020-2031)
Figure 60. Global Furosemide Injection Price (US$/Unit) by Application (2020-2031)
Figure 61. Furosemide Injection Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
